首页 > 最新文献

Journal of Investigational Allergology and Clinical Immunology最新文献

英文 中文
Regarding "Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Induced by Meropenem in a Patient Receiving Avelumab and Subsequent Flare-up". 关于“美罗培南在接受Avelumab治疗的患者中引起的嗜酸性粒细胞增多和全身症状(DRESS)的药物反应和随后的急性发作”。
IF 4.8 3区 医学 Q1 ALLERGY Pub Date : 2025-12-03 DOI: 10.18176/jiaci.1133
Öner Özdemir
{"title":"Regarding \"Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Induced by Meropenem in a Patient Receiving Avelumab and Subsequent Flare-up\".","authors":"Öner Özdemir","doi":"10.18176/jiaci.1133","DOIUrl":"https://doi.org/10.18176/jiaci.1133","url":null,"abstract":"","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"0"},"PeriodicalIF":4.8,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term Prophylaxis With Lanadelumab in Patients With Angioedema Due to C1 Inhibitor Deficiency: A Real-life Study in Spain. Lanadelumab对C1抑制剂缺乏引起的血管性水肿患者的长期预防:西班牙的一项现实研究
IF 4.8 3区 医学 Q1 ALLERGY Pub Date : 2025-12-03 DOI: 10.18176/jiaci.1120
Isamar De Agrela-Mendes, Ana Entrala, Elsa Phillips-Angles, Tamara Pérez-Robles, Rosario Cabañas, Teresa Caballero
{"title":"Long-term Prophylaxis With Lanadelumab in Patients With Angioedema Due to C1 Inhibitor Deficiency: A Real-life Study in Spain.","authors":"Isamar De Agrela-Mendes, Ana Entrala, Elsa Phillips-Angles, Tamara Pérez-Robles, Rosario Cabañas, Teresa Caballero","doi":"10.18176/jiaci.1120","DOIUrl":"https://doi.org/10.18176/jiaci.1120","url":null,"abstract":"","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"0"},"PeriodicalIF":4.8,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence, Treatment Trajectories, and Environmental Exacerbation Factors in Asthma: A Regional Study in Andalusia. 哮喘的患病率、治疗轨迹和环境恶化因素:安达卢西亚地区的一项研究。
IF 4.8 3区 医学 Q1 ALLERGY Pub Date : 2025-12-03 DOI: 10.18176/jiaci.1096
Alberto Moreno-Conde, Jesús Moreno-Conde, Pedro Guardia-Martínez, Ángel Vilches-Arenas, Claudia Rodríguez, Virginia De Luque-Piñana

Background and objectives: Asthma is a chronic respiratory condition whose prevalence varies across different regions and populations. In Andalusia, detailed data on the characteristics of asthma patients are lacking, thus limiting effective clinical management and health care planning. Objective: Our objective was to characterize patients diagnosed with asthma in Andalusia.

Material and methods: To our knowledge, this study comprises the largest cohort of asthma patients in Spain. We characterized 726 006 asthma patients based on prevalence, exacerbations, comorbidities, and pharmacological treatment. We covered the whole population, with subanalyses comparing rural-urban settings and coastal-inland regions.

Results: The overall prevalence of asthma in Andalusia was 8.57%. The disease was more prevalent in females, although it was more common in males until the age of 15 years. The most frequent comorbidities were arthrosis and spondylosis. Almost three-quarters (70.73%) of newly diagnosed asthma patients received treatment, the most common being SABAs (31.56%), LTRAs (16.13%), and systemic corticosteroids (13.94%). After initial treatment, 35.15% of patients did not receive follow-up care. Treatment was stepped up in 28.68%, stepped down in 20.75%, and switched in 15.43%.

Conclusions: Our results provide a detailed characterization of the Andalusian population in terms of prevalence, comorbidities, and treatment trajectories and proved consistent with findings from other Spanish regions. We also observed geographical discrepancies in asthma prevalence when comparing rural-urban settings and coastal-inland regions.

背景和目的:哮喘是一种慢性呼吸系统疾病,其患病率在不同地区和人群中存在差异。在安达卢西亚,缺乏关于哮喘患者特征的详细数据,从而限制了有效的临床管理和卫生保健规划。目的:我们的目的是表征在安达卢西亚被诊断为哮喘的患者。材料和方法:据我们所知,本研究包括西班牙最大的哮喘患者队列。我们根据患病率、恶化、合并症和药物治疗对726006例哮喘患者进行了特征分析。我们覆盖了整个人口,并对农村-城市环境和沿海-内陆地区进行了亚分析。结果:安达卢西亚地区哮喘总患病率为8.57%。这种疾病在女性中更为普遍,尽管在15岁之前在男性中更为常见。最常见的合并症是关节病和颈椎病。近四分之三(70.73%)的新诊断哮喘患者接受了治疗,最常见的是SABAs(31.56%)、LTRAs(16.13%)和全身皮质类固醇(13.94%)。初次治疗后,35.15%的患者未接受随访。强化治疗占28.68%,降压治疗占20.75%,切换治疗占15.43%。结论:我们的研究结果提供了安达卢西亚人口在患病率、合并症和治疗轨迹方面的详细特征,并与西班牙其他地区的研究结果一致。在比较城乡环境和沿海内陆地区时,我们还观察到哮喘患病率的地理差异。
{"title":"Prevalence, Treatment Trajectories, and Environmental Exacerbation Factors in Asthma: A Regional Study in Andalusia.","authors":"Alberto Moreno-Conde, Jesús Moreno-Conde, Pedro Guardia-Martínez, Ángel Vilches-Arenas, Claudia Rodríguez, Virginia De Luque-Piñana","doi":"10.18176/jiaci.1096","DOIUrl":"https://doi.org/10.18176/jiaci.1096","url":null,"abstract":"<p><strong>Background and objectives: </strong>Asthma is a chronic respiratory condition whose prevalence varies across different regions and populations. In Andalusia, detailed data on the characteristics of asthma patients are lacking, thus limiting effective clinical management and health care planning. Objective: Our objective was to characterize patients diagnosed with asthma in Andalusia.</p><p><strong>Material and methods: </strong>To our knowledge, this study comprises the largest cohort of asthma patients in Spain. We characterized 726 006 asthma patients based on prevalence, exacerbations, comorbidities, and pharmacological treatment. We covered the whole population, with subanalyses comparing rural-urban settings and coastal-inland regions.</p><p><strong>Results: </strong>The overall prevalence of asthma in Andalusia was 8.57%. The disease was more prevalent in females, although it was more common in males until the age of 15 years. The most frequent comorbidities were arthrosis and spondylosis. Almost three-quarters (70.73%) of newly diagnosed asthma patients received treatment, the most common being SABAs (31.56%), LTRAs (16.13%), and systemic corticosteroids (13.94%). After initial treatment, 35.15% of patients did not receive follow-up care. Treatment was stepped up in 28.68%, stepped down in 20.75%, and switched in 15.43%.</p><p><strong>Conclusions: </strong>Our results provide a detailed characterization of the Andalusian population in terms of prevalence, comorbidities, and treatment trajectories and proved consistent with findings from other Spanish regions. We also observed geographical discrepancies in asthma prevalence when comparing rural-urban settings and coastal-inland regions.</p>","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"0"},"PeriodicalIF":4.8,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Catalase and Hypersensitivity to Avocado. 过氧化氢酶和对鳄梨过敏。
IF 4.8 3区 医学 Q1 ALLERGY Pub Date : 2025-12-03 DOI: 10.18176/jiaci.1128
Öner Özdemir
{"title":"Catalase and Hypersensitivity to Avocado.","authors":"Öner Özdemir","doi":"10.18176/jiaci.1128","DOIUrl":"10.18176/jiaci.1128","url":null,"abstract":"","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"0"},"PeriodicalIF":4.8,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Cross-Reactive Allergens in Mushroom Allergy: A Case Report in a 17-Year-Old Girl in Japan. 蘑菇过敏的新型交叉反应性过敏原:一名17岁日本女孩的病例报告。
IF 4.8 3区 医学 Q1 ALLERGY Pub Date : 2025-12-03 DOI: 10.18176/jiaci.1125
Makoto Nojo, Shintaro Suzuki, Tomoki Uno, Yoshitaka Uchida, Yoshito Miyata, Hironori Sagara, Akihiko Tanaka
{"title":"Novel Cross-Reactive Allergens in Mushroom Allergy: A Case Report in a 17-Year-Old Girl in Japan.","authors":"Makoto Nojo, Shintaro Suzuki, Tomoki Uno, Yoshitaka Uchida, Yoshito Miyata, Hironori Sagara, Akihiko Tanaka","doi":"10.18176/jiaci.1125","DOIUrl":"https://doi.org/10.18176/jiaci.1125","url":null,"abstract":"","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"0"},"PeriodicalIF":4.8,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strongyloides stercoralis Infection, Imatinib, and DRESS. 粪圆线虫感染,伊马替尼和DRESS。
IF 4.8 3区 医学 Q1 ALLERGY Pub Date : 2025-12-03 DOI: 10.18176/jiaci.1129
Öner Özdemir
{"title":"Strongyloides stercoralis Infection, Imatinib, and DRESS.","authors":"Öner Özdemir","doi":"10.18176/jiaci.1129","DOIUrl":"https://doi.org/10.18176/jiaci.1129","url":null,"abstract":"","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"0"},"PeriodicalIF":4.8,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Allergy to Bee Pollen Supplement: Identification of Major Royal Jelly Protein 1 as the Culprit Allergen. 对蜂花粉补充剂的过敏:鉴定主要蜂王浆蛋白1为罪魁祸首过敏原。
IF 4.8 3区 医学 Q1 ALLERGY Pub Date : 2025-11-26 DOI: 10.18176/jiaci.1124
Alejandro De la Torre Carrión, Estela S Castromil-Benito, Jorge Parrón-Ballesteros, Luisa Iglesias-Pena, Carlos Pastor-Vargas, Montserrat Fernandez-Rivas
{"title":"Allergy to Bee Pollen Supplement: Identification of Major Royal Jelly Protein 1 as the Culprit Allergen.","authors":"Alejandro De la Torre Carrión, Estela S Castromil-Benito, Jorge Parrón-Ballesteros, Luisa Iglesias-Pena, Carlos Pastor-Vargas, Montserrat Fernandez-Rivas","doi":"10.18176/jiaci.1124","DOIUrl":"https://doi.org/10.18176/jiaci.1124","url":null,"abstract":"","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"0"},"PeriodicalIF":4.8,"publicationDate":"2025-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145607259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Omalizumab as Premedication for Hypersensitivity Reactions Refractory to Asparaginase Desensitization in Children With Acute Lymphoblastic Leukemia. Omalizumab作为急性淋巴细胞白血病儿童天冬酰胺酶脱敏难治性超敏反应的预用药。
IF 4.8 3区 医学 Q1 ALLERGY Pub Date : 2025-11-25 DOI: 10.18176/jiaci.1118
Teodorikez-Wilfox Jimenez-Rodriguez, Angela Rico Rodes, Amparo Burgos San Jose, María Del Cañizo Moreira, Laura Ureña Horno, Maria E Valerio Alonso, Andrea Cano Rodriguez, Clara P Gallego Velez, María P González Delgado, María Tasso Cereceda
{"title":"Omalizumab as Premedication for Hypersensitivity Reactions Refractory to Asparaginase Desensitization in Children With Acute Lymphoblastic Leukemia.","authors":"Teodorikez-Wilfox Jimenez-Rodriguez, Angela Rico Rodes, Amparo Burgos San Jose, María Del Cañizo Moreira, Laura Ureña Horno, Maria E Valerio Alonso, Andrea Cano Rodriguez, Clara P Gallego Velez, María P González Delgado, María Tasso Cereceda","doi":"10.18176/jiaci.1118","DOIUrl":"https://doi.org/10.18176/jiaci.1118","url":null,"abstract":"","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"0"},"PeriodicalIF":4.8,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145607307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chicory-Induced Anaphylaxis: Characterization of Peroxidase as a Novel Allergen. 菊苣诱导的过敏反应:表征过氧化物酶作为一种新的过敏原。
IF 4.8 3区 医学 Q1 ALLERGY Pub Date : 2025-11-20 DOI: 10.18176/jiaci.1113
María Otal-Buesa, Leyre Baptista-Serna, Emilio Nuñez-Borque, Sergio Fernández-Bravo, Vanesa Esteban, Joaquín Sastre
{"title":"Chicory-Induced Anaphylaxis: Characterization of Peroxidase as a Novel Allergen.","authors":"María Otal-Buesa, Leyre Baptista-Serna, Emilio Nuñez-Borque, Sergio Fernández-Bravo, Vanesa Esteban, Joaquín Sastre","doi":"10.18176/jiaci.1113","DOIUrl":"https://doi.org/10.18176/jiaci.1113","url":null,"abstract":"","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"0"},"PeriodicalIF":4.8,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145589879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the Allergenic Relevance of Vespula alascensis Venom: Implications for Venom Immunotherapy. 评估黄脉蛇毒液的致敏性:对毒液免疫治疗的影响。
IF 4.8 3区 医学 Q1 ALLERGY Pub Date : 2025-11-20 DOI: 10.18176/jiaci.1108
Benjamin O Slusarenko, Klara F Borrmann, Claudia Knappe, Jonathan Vogel, Benjamin Schnautz, Stéphanie Kler, Tilo Biedermann, Knut Brockow, Ulf Darsow, Thalia Carreno Velazquez, Elisabetta Francescato, Simon J Hewings, Matthias F Kramer, Matthew D Heath, Gunnar Dittmar, Christiane Hilger, Ralph S Peters, Carsten B Schmidt-Weber, Bernadette Eberlein, Simon Blank

Background and objectives: Venom immunotherapy (VIT) is an effective treatment for yellow jacket venom (YJV) allergy. It is often based on mixtures of venom from different species. Recent taxonomic re-evaluation has revealed that widely used VIT preparations contain venom from Vespula alascensis, a North American species, rather than venom from the Palearctic Vespula vulgaris. To assess the allergenic relevance of V alascensis venom for European patients and evaluate its suitability for inclusion in VIT preparations.

Methods: The ability of V alascensis and V vulgaris venom to activate effector cells from YJV-allergic patients from Germany was compared using the basophil activation test. Patients' sIgE reactivity was assessed using ELISA, inhibition ELISA, CAP inhibition, and Western blot. Proteomic analysis of the venoms was also conducted.

Results: Basophil activation tests showed highly similar activation profiles for V alascensis and V vulgaris venoms. Moreover, ELISA and inhibition analyses revealed comparable overall sIgE reactivity for both venoms. In contrast, Western blot analysis demonstrated similar sIgE profiles for antigen 5 allergens, although phospholipase A1 allergens were differentially detected. Proteomic analysis revealed no differences in the major allergens of the 2 venoms.

Conclusion: This study demonstrates the functional similarity between V alascensis and V vulgaris venoms in allergic responses. Moreover, it highlights the clinical relevance of V alascensis for YJV-sensitized European patients and supports its inclusion in YJV VIT preparations in Europe.

背景与目的:蛇毒免疫疗法(VIT)是治疗黄马甲毒(YJV)过敏的有效方法。它通常是基于来自不同物种的毒液的混合物。最近的分类重新评估表明,广泛使用的VIT制剂含有来自北美Vespula alascensis的毒液,而不是来自古北Vespula vulgaris的毒液。目的:评估欧洲患者与白螺旋体毒的致敏相关性,并评估其在VIT制剂中的适用性。方法:采用嗜碱性细胞激活试验,比较白毒V和寻常毒V对德国yjv过敏患者效应细胞的激活能力。采用酶联免疫吸附试验(ELISA)、抑制酶联免疫吸附试验(ELISA)、CAP抑制和Western blot检测患者sIgE反应性。还对毒液进行了蛋白质组学分析。结果:嗜碱性粒细胞活化试验显示,嗜碱性粒细胞活化谱与嗜碱性粒细胞活化谱高度相似。此外,ELISA和抑制分析显示两种毒液的sIgE总体反应性相当。相比之下,Western blot分析显示抗原5过敏原的sIgE谱相似,尽管磷脂酶A1过敏原的检测差异较大。蛋白质组学分析显示,两种毒液的主要过敏原没有差异。结论:本研究证实了白螺旋体和寻常螺旋体在过敏反应中的功能相似性。此外,它强调了valascensis与YJV敏感的欧洲患者的临床相关性,并支持将其纳入欧洲的YJV VIT制剂。
{"title":"Assessing the Allergenic Relevance of Vespula alascensis Venom: Implications for Venom Immunotherapy.","authors":"Benjamin O Slusarenko, Klara F Borrmann, Claudia Knappe, Jonathan Vogel, Benjamin Schnautz, Stéphanie Kler, Tilo Biedermann, Knut Brockow, Ulf Darsow, Thalia Carreno Velazquez, Elisabetta Francescato, Simon J Hewings, Matthias F Kramer, Matthew D Heath, Gunnar Dittmar, Christiane Hilger, Ralph S Peters, Carsten B Schmidt-Weber, Bernadette Eberlein, Simon Blank","doi":"10.18176/jiaci.1108","DOIUrl":"https://doi.org/10.18176/jiaci.1108","url":null,"abstract":"<p><strong>Background and objectives: </strong>Venom immunotherapy (VIT) is an effective treatment for yellow jacket venom (YJV) allergy. It is often based on mixtures of venom from different species. Recent taxonomic re-evaluation has revealed that widely used VIT preparations contain venom from Vespula alascensis, a North American species, rather than venom from the Palearctic Vespula vulgaris. To assess the allergenic relevance of V alascensis venom for European patients and evaluate its suitability for inclusion in VIT preparations.</p><p><strong>Methods: </strong>The ability of V alascensis and V vulgaris venom to activate effector cells from YJV-allergic patients from Germany was compared using the basophil activation test. Patients' sIgE reactivity was assessed using ELISA, inhibition ELISA, CAP inhibition, and Western blot. Proteomic analysis of the venoms was also conducted.</p><p><strong>Results: </strong>Basophil activation tests showed highly similar activation profiles for V alascensis and V vulgaris venoms. Moreover, ELISA and inhibition analyses revealed comparable overall sIgE reactivity for both venoms. In contrast, Western blot analysis demonstrated similar sIgE profiles for antigen 5 allergens, although phospholipase A1 allergens were differentially detected. Proteomic analysis revealed no differences in the major allergens of the 2 venoms.</p><p><strong>Conclusion: </strong>This study demonstrates the functional similarity between V alascensis and V vulgaris venoms in allergic responses. Moreover, it highlights the clinical relevance of V alascensis for YJV-sensitized European patients and supports its inclusion in YJV VIT preparations in Europe.</p>","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"0"},"PeriodicalIF":4.8,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145589826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Investigational Allergology and Clinical Immunology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1